TW202000037A - Compound liposome additive of soy lecithin-coated vitamin and preparing method thereof capable of effectively enhancing growth of chicken - Google Patents
Compound liposome additive of soy lecithin-coated vitamin and preparing method thereof capable of effectively enhancing growth of chicken Download PDFInfo
- Publication number
- TW202000037A TW202000037A TW107120545A TW107120545A TW202000037A TW 202000037 A TW202000037 A TW 202000037A TW 107120545 A TW107120545 A TW 107120545A TW 107120545 A TW107120545 A TW 107120545A TW 202000037 A TW202000037 A TW 202000037A
- Authority
- TW
- Taiwan
- Prior art keywords
- lecithin
- vitamin
- ethanol
- weight ratio
- aqueous solution
- Prior art date
Links
- 239000002502 liposome Substances 0.000 title claims abstract description 96
- 229940088594 vitamin Drugs 0.000 title claims abstract description 78
- 229930003231 vitamin Natural products 0.000 title claims abstract description 78
- 235000013343 vitamin Nutrition 0.000 title claims abstract description 78
- 239000011782 vitamin Substances 0.000 title claims abstract description 78
- 150000003722 vitamin derivatives Chemical class 0.000 title claims abstract description 41
- 150000001875 compounds Chemical class 0.000 title claims abstract description 25
- 239000000654 additive Substances 0.000 title claims abstract description 23
- 230000000996 additive effect Effects 0.000 title claims abstract description 22
- 238000000034 method Methods 0.000 title claims abstract description 20
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 title claims abstract description 10
- 239000008347 soybean phospholipid Substances 0.000 title claims abstract description 10
- 241000287828 Gallus gallus Species 0.000 title description 12
- 230000002708 enhancing effect Effects 0.000 title 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 178
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 143
- 239000000787 lecithin Substances 0.000 claims abstract description 143
- 229940067606 lecithin Drugs 0.000 claims abstract description 143
- 235000010445 lecithin Nutrition 0.000 claims abstract description 143
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 86
- 239000007864 aqueous solution Substances 0.000 claims abstract description 72
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 claims abstract description 70
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 63
- 239000011719 vitamin A Substances 0.000 claims abstract description 63
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 51
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims abstract description 51
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 51
- 229940045997 vitamin a Drugs 0.000 claims abstract description 51
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 43
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 43
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 43
- 239000011709 vitamin E Substances 0.000 claims abstract description 43
- 229940046009 vitamin E Drugs 0.000 claims abstract description 42
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 38
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims abstract description 35
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims abstract description 34
- 235000005282 vitamin D3 Nutrition 0.000 claims abstract description 34
- 239000011647 vitamin D3 Substances 0.000 claims abstract description 34
- 235000012711 vitamin K3 Nutrition 0.000 claims abstract description 34
- 239000011652 vitamin K3 Substances 0.000 claims abstract description 34
- 229940021056 vitamin d3 Drugs 0.000 claims abstract description 33
- 238000002156 mixing Methods 0.000 claims abstract description 8
- 239000010409 thin film Substances 0.000 claims abstract description 7
- 239000002245 particle Substances 0.000 claims description 43
- 239000000243 solution Substances 0.000 claims description 38
- 239000010408 film Substances 0.000 claims description 23
- 239000013589 supplement Substances 0.000 claims description 21
- -1 vitamin compound lipid Chemical class 0.000 claims description 21
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 18
- 150000002632 lipids Chemical class 0.000 claims description 18
- 238000003756 stirring Methods 0.000 claims description 17
- 235000013305 food Nutrition 0.000 claims description 16
- 238000002360 preparation method Methods 0.000 claims description 13
- 238000010438 heat treatment Methods 0.000 claims description 8
- 239000002244 precipitate Substances 0.000 claims description 8
- 238000000967 suction filtration Methods 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 6
- 150000003904 phospholipids Chemical class 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- 229940101578 microlipid Drugs 0.000 claims description 2
- 244000144977 poultry Species 0.000 description 19
- 235000013594 poultry meat Nutrition 0.000 description 19
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 12
- 229940083466 soybean lecithin Drugs 0.000 description 12
- 235000013330 chicken meat Nutrition 0.000 description 10
- 239000000203 mixture Substances 0.000 description 9
- 238000013097 stability assessment Methods 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 238000001514 detection method Methods 0.000 description 7
- 238000010586 diagram Methods 0.000 description 7
- 239000003651 drinking water Substances 0.000 description 6
- 235000020188 drinking water Nutrition 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 239000003925 fat Substances 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 6
- 244000061458 Solanum melongena Species 0.000 description 5
- 235000002597 Solanum melongena Nutrition 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 230000036737 immune function Effects 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000000386 microscopy Methods 0.000 description 5
- 230000035515 penetration Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- 238000013517 stratification Methods 0.000 description 4
- 230000008859 change Effects 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000001804 emulsifying effect Effects 0.000 description 3
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000002356 single layer Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000714177 Murine leukemia virus Species 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 229930003448 Vitamin K Natural products 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 235000013345 egg yolk Nutrition 0.000 description 2
- 210000002969 egg yolk Anatomy 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 230000004720 fertilization Effects 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 2
- 239000006041 probiotic Substances 0.000 description 2
- 235000018291 probiotics Nutrition 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000001550 time effect Effects 0.000 description 2
- 230000004382 visual function Effects 0.000 description 2
- 235000019168 vitamin K Nutrition 0.000 description 2
- 239000011712 vitamin K Substances 0.000 description 2
- 150000003721 vitamin K derivatives Chemical class 0.000 description 2
- 229940046010 vitamin k Drugs 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- GNFTZDOKVXKIBK-UHFFFAOYSA-N 3-(2-methoxyethoxy)benzohydrazide Chemical compound COCCOC1=CC=CC(C(=O)NN)=C1 GNFTZDOKVXKIBK-UHFFFAOYSA-N 0.000 description 1
- 208000000412 Avitaminosis Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- 239000000232 Lipid Bilayer Substances 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229940036811 bone meal Drugs 0.000 description 1
- 239000002374 bone meal Substances 0.000 description 1
- 210000004913 chyme Anatomy 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 235000020997 lean meat Nutrition 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002114 nanocomposite Substances 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015816 nutrient absorption Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 238000003921 particle size analysis Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 150000003716 vitamin K3 derivatives Chemical class 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 208000030401 vitamin deficiency disease Diseases 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
本發明係關於一種複方微脂粒添加物,特別係關於一種大豆卵磷脂包覆維生素之複方微脂粒家禽食品添加物。The invention relates to a compound lipid particle additive, in particular to a compound lipid particle poultry food additive in which vitamins are coated with soybean lecithin.
維生素乃維持雞隻等家禽生理功能必須物質,倘若雞隻飼料中維生素攝取不均勻即可能導致疾病產生,而帶來經濟損失後果。目前家禽維生素缺乏可歸類以下主因:Vitamins are necessary to maintain the physiological functions of chickens and other poultry. If the intake of vitamins in chicken feed is not uniform, it may cause disease and economic consequences. The current vitamin deficiency in poultry can be classified into the following main causes:
一、飼料配比不當:由於飼料中的維生素含量不同,例如玉米含維生素A,大豆餅﹙粕﹚為維生素E多,骨粉以維生素B12較多。因此飼料配比不均勻或家禽偏好特定飼料時,會造成某些維生素過高導致另一種維生素排泄掉,進而造成家禽對於維生素攝取不足,因此如何維持維生素的均衡則是飼料及飲水配比時需要注意的事項。1. Improper feed ratio: due to the different vitamin content in the feed, for example, corn contains vitamin A, soybean cake (meal) contains more vitamin E, and bone meal contains more vitamin B12. Therefore, when the feed ratio is not uniform or the poultry prefers a specific feed, some vitamins will be too high and another vitamin will be excreted, which will lead to insufficient intake of vitamins by the poultry. Therefore, how to maintain the balance of vitamins is required for the ratio of feed and drinking water. Matters needing attention.
二、加工過程與儲存方式:許多維生素於生產後,在飼料保存與飼料加工過程中皆有時間上的效應,見間導致維生素的不穩定。因此使用飼料或添加維生素時須注意時間效應問題。除此之外,維生素也容易受到溫度、濕度、陽光、酸鹼等影響。2. Processing and storage methods: Many vitamins have a time effect during feed storage and feed processing after production, which can lead to vitamin instability. Therefore, pay attention to the time effect when using feed or adding vitamins. In addition, vitamins are also susceptible to temperature, humidity, sunlight, acid and alkali.
三、濫用抗生素:由於市場因素養殖戶大量使用抗生素,進而導致家禽腸道中微生物合成維生素不足。植物油及動物脂肪添加至飼料中除了提高日量的濃度之外,並能降低消化糜的通過率進而提升養分的吸收,解決家禽腸道中微生物合成維生素不足的問題。通常家禽生長初期因為脂肪乳化能力較弱導致對脂肪的消化能力較弱,此時若能適時的以乳化劑提升乳化功效將能提升家禽脂肪的利用率。由於大豆卵磷脂含有亞油酸、亞麻酸等多種不飽和脂肪酸,因此大豆磷脂添加於飼料中可以促進脂肪的新陳代謝,分解及消化並能吸收多餘的膽固醇,提高家禽的瘦肉率(李曼,2011)。研究發現,卵磷脂包覆維生素B6後,在雞嗉囊中能延緩釋放(Heba Abd El Azim, et al, 2015)。因此卵磷脂不但能添加於飼料中作為營養成分,如添加於液態飼料中能有助於乳化的安定性,卵磷脂如作為包覆材料時,更能增加包覆物的滲透性。3. Abuse of antibiotics: Due to market factors, farmers use antibiotics in large quantities, which in turn leads to inadequate microbial synthesis of vitamins in the gut of poultry. The addition of vegetable oils and animal fats to feeds not only improves the daily concentration, but also reduces the digestive chyme throughput rate and thus enhances nutrient absorption, solving the problem of insufficient vitamin synthesis in the poultry gut. Generally, the weak fat emulsifying ability in the early growth stage of poultry leads to the weak digestion ability of fat. At this time, if the emulsifier can be used to improve the emulsifying effect, the utilization rate of poultry fat can be improved. Because soybean lecithin contains linoleic acid, linolenic acid and other unsaturated fatty acids, soy lecithin added to the feed can promote fat metabolism, decomposition and digestion and can absorb excess cholesterol, increase the lean meat rate of poultry (Li Man, 2011). The study found that lecithin coated with vitamin B6 can delay the release in chicken crops (Heba Abd El Azim, et al, 2015). Therefore, lecithin can not only be added to the feed as a nutrient component, such as added to the liquid feed can contribute to the stability of emulsification, when used as a coating material, lecithin can also increase the permeability of the coating.
雖然卵磷脂還具有乳化特性能阻止膽固醇在血管壁沉積,以及具有乳化脂類能增強肌體免疫功能,並且能促進吞噬細胞的吞噬功能和淋巴細胞增殖能力,但是其主要來源高純度的卵磷脂價格高昂。卵磷脂含量55%以下的產品通常應用在保健食品或營養品中,或是做為醫藥品的輔料。卵磷脂含量60至80%的產品通常應用於化妝品或作為藥用輔料。卵磷脂含量90%以上的產品則通常應用在製藥行業,而且純度越高氧化性能越強,需做氫化處理然後保存,未氫化處理的高純度卵磷脂則要在充氮的密封容器中保存,間接也提高了持有的成本。Although lecithin also has emulsifying properties to prevent cholesterol from depositing on the walls of blood vessels, and emulsified lipids can enhance the body's immune function, and can promote the phagocytic function of phagocytes and lymphocyte proliferation, but its main source is high-purity lecithin price high. Products with a lecithin content of less than 55% are usually used in health foods or nutritional products, or as an adjunct to pharmaceutical products. Products with a lecithin content of 60 to 80% are usually used in cosmetics or as pharmaceutical excipients. Products with a lecithin content of more than 90% are usually used in the pharmaceutical industry, and the higher the purity, the stronger the oxidizing performance. It needs to be hydrogenated and then stored. The non-hydrogenated high-purity lecithin should be stored in a nitrogen-filled sealed container. Indirectly, it also increases the cost of holding.
動物性卵磷脂如蛋黃所含卵磷脂占蛋黃脂質的73%,其飽和程度較佳但價格也較高。植物性卵磷脂則以大豆最為常見,大豆卵磷脂所含卵磷脂約29%~39%左右,純度不高但價格相對低廉,若能以低純度食品卵磷脂精煉後進行維生素微脂粒製備,應能大幅降低成本。現階段奈米材料的開發技術雖然已在食品添加劑和食品相關成分的應用中普遍使用,但做為農業和飼料開發的應用較不常見,許多相關文獻亦尚無探討以低純度食品卵磷脂包覆維生素A、D3 、E、K3 之卵磷脂使用純度、包覆維生素使用比例、維生素濃度等相關研究,因此複方微脂粒維生素應用在飼料添加劑的奈米複合材料開發技術,將是未來發展趨勢。Animal lecithin, such as egg yolk, contains 73% of egg yolk lipids. Its saturation range is better but the price is higher. Soy lecithin contains about 29% to 39% of vegetable lecithin. Soy lecithin contains about 29% to 39% of the lecithin. The purity is not high but the price is relatively low. If it can be refined with low-purity food lecithin, vitamin liposomes can be prepared. Should be able to significantly reduce costs. At present, although the development technology of nanomaterials has been widely used in the application of food additives and food-related ingredients, it is less common as an application in the development of agriculture and feed. Many related literatures have not discussed the use of low-purity food lecithin packages. Relevant researches on the use purity of lecithin covered with vitamins A, D 3 , E, K 3 , the use ratio of coated vitamins, vitamin concentration, etc. Therefore, the development of nano-composite materials for compound lipid vitamins in feed additives will be the future development trend.
本發明之主要目的在提供一種能有效幫助雞隻成長的大豆卵磷脂包覆維生素之複方微脂粒添加物。The main purpose of the present invention is to provide a compound lipid particle supplement of soybean lecithin coated vitamins that can effectively help chickens grow.
本發明之另一目的在提供一種安定性高的大豆卵磷脂包覆維生素之複方微脂粒添加物。Another object of the present invention is to provide a compound lipid particle supplement of highly stable soybean lecithin-coated vitamins.
本發明之再一目的在提供一種具有上述功效的複方微脂粒添加物的製備方法。Another object of the present invention is to provide a method for preparing a compound liposome additive with the above-mentioned effects.
為達成上述目的,本發明在一較佳實施例係包含以卵磷脂分別包覆維生素A、D3、E、K3之四種微脂粒,其特徵在於:該卵磷脂與該維生素A之重量比為2:0.01至2:0.1,該卵磷脂與該維生素D3之重量比為2:0.2至2:0.5,該卵磷脂與該維生素E之重量比為2:0.2至2:0.4,該卵磷脂與該維生素K3之重量比為2:0.4至2:1。In order to achieve the above object, a preferred embodiment of the present invention includes four liposomes coated with vitamin A, D3, E, and K3 with lecithin, characterized in that the weight ratio of the lecithin to the vitamin A is Is 2:0.01 to 2:0.1, the weight ratio of the lecithin to the vitamin D3 is 2:0.2 to 2:0.5, the weight ratio of the lecithin to the vitamin E is 2:0.2 to 2:0.4, the lecithin The weight ratio with this vitamin K3 is 2:0.4 to 2:1.
在一些實施例中,更具體的範圍可以是該卵磷脂與該維生素A之重量比為2:0.1,該卵磷脂與該維生素D3之重量比為2:0.5,該卵磷脂與該維生素E之重量比為2:0.4,該卵磷脂與該維生素K3之重量比為2:1。In some embodiments, a more specific range may be a weight ratio of the lecithin to the vitamin A of 2:0.1, a weight ratio of the lecithin to the vitamin D3 of 2:0.5, a weight ratio of the lecithin to the vitamin E The weight ratio is 2:0.4, and the weight ratio of the lecithin to the vitamin K3 is 2:1.
在一些實施例中,該四種微脂粒的粒徑皆在123.3±0.5 nm至319.98±44.8 nm之間,以具有較良好的安定性。In some embodiments, the particle sizes of the four liposomes are all between 123.3±0.5 nm and 319.98±44.8 nm, so as to have good stability.
該複方微脂粒添加物的製備方法較佳包含以下步驟:(a) 將該卵磷脂與乙醇配置成2%卵磷脂乙醇水溶液備用;(b)將該維生素A、D3、E、K3依照其重量比分別與該2%卵磷脂乙醇水溶液混合形成不同濃度之維生素卵磷脂乙醇水溶液;(c)將不同濃度之該維生素卵磷脂乙醇水溶液分別進行減壓濃縮形成薄膜;(d)將該些薄膜分別加入純水或乙醇,以震盪機震盪至薄膜全數掉落融入水中,取得多層微脂粒溶液;(e) 將該些多層微脂粒溶液分別使用超音波細胞震碎機震盪後取得不同濃度的維生素A、D3、E、K3微脂粒水溶液;(f)混合該些不同濃度的維生素A、D3、E、K3微脂粒水溶液形成複方微脂粒添加物。The preparation method of the compound lipid particle additive preferably includes the following steps: (a) disposing the lecithin and ethanol into a 2% aqueous solution of lecithin ethanol for use; (b) according to the vitamin A, D3, E, K3 The weight ratio is mixed with the 2% aqueous lecithin ethanol solution to form different concentrations of vitamin lecithin ethanol aqueous solution; (c) the different concentrations of the vitamin lecithin ethanol aqueous solution are concentrated under reduced pressure to form films; (d) the films Add pure water or ethanol separately, shake with a shaker until all the film is dropped into the water, and obtain a multi-layered liposome solution; (e) shake these multi-layered liposome solutions with an ultrasonic cell shaker to obtain different concentrations Vitamin A, D3, E, K3 liposome aqueous solution; (f) Mix these different concentrations of vitamin A, D3, E, K3 liposome aqueous solution to form a compound liposome additive.
在一些實施例中,可以於步驟(b)之前先將該維生素A、D3、E與乙醇分別調配成維生素A、D3、E之乙醇水溶液,以及將該維生素K3與純水調配成維生素K3之水溶液,再與該2%卵磷脂乙醇水溶液進行混合。In some embodiments, before step (b), the vitamins A, D3, E, and ethanol may be formulated into an aqueous solution of vitamins A, D3, and E, respectively, and the vitamin K3 and pure water may be formulated into vitamin K3. The aqueous solution is then mixed with the 2% ethanol solution of lecithin.
在一些實施例中,其中步驟(a) 之該卵磷脂係以純度30%左右之低純度食品卵磷脂以丙酮及乙醇進行萃取取得純度70%以上之該卵磷脂。In some embodiments, the lecithin in step (a) is extracted with low-purity food lecithin with a purity of about 30% using acetone and ethanol to obtain the lecithin with a purity of more than 70%.
在一些實施例中,其中該卵磷脂之萃取方法包含以下步驟:(g)將純度30%左右之低純度食品卵磷脂與丙酮依1:2重量比例混合,使用電磁加熱攪拌器攪拌後靜置取去上層清液;(h) 重複步驟(g)二次;(i)最後一次攪拌完畢後進行抽氣過濾取其沉澱物;(j)將該沉澱物與純度95%乙醇1:2重量比例混合,使用電磁加熱攪拌器攪拌,每次攪拌後立即進行抽氣過濾;(k)過濾後取得溶液進行減壓濃縮將溶劑完全去除取得純度70%以上之該卵磷脂。In some embodiments, the method for extracting lecithin includes the following steps: (g) mixing low-purity food lecithin with a purity of about 30% and acetone at a weight ratio of 1:2, stirring with an electromagnetic heating stirrer, and then standing Remove the supernatant; (h) Repeat step (g) twice; (i) After the last stirring, perform suction filtration to take the precipitate; (j) The precipitate and the purity of 95% ethanol 1:2 weight Proportional mixing, stirring using an electromagnetic heating stirrer, suction filtration is performed immediately after each stirring; (k) The solution obtained after filtration is concentrated under reduced pressure to completely remove the solvent to obtain the lecithin with a purity of more than 70%.
在一些實施例中,其中步驟(e) 中取得該些不同濃度的維生素A、D3、E及K3微脂粒水溶液的濃度分別為0.5%、0.25%、0.2%及1%。In some embodiments, the concentrations of the vitamin A, D3, E and K3 liposome aqueous solutions obtained in step (e) are 0.5%, 0.25%, 0.2% and 1%, respectively.
維生素分為脂溶性維生素和水溶性維生素兩類,維生素A能幫助家禽視覺機能,繁殖機能,免疫機能;維生素E達到抗氧化,保護生物膜完整,提高產蛋率,受精率,孵化率;維生素D3則促進腸胃對鈣磷的吸收,提高免疫機能;家禽缺乏維生素K時,容易出血且不易凝固。因此本發明基於上列因素,利用微粒載體包覆維生素A、D3、E及K3材料之後,製成一種綜合性含維生素微粒載體之家禽飲品添加物,將可預防家禽飲食維生素攝取不均勻的問題。Vitamins are divided into fat-soluble vitamins and water-soluble vitamins. Vitamin A can help poultry visual function, reproduction function, immune function; vitamin E can achieve antioxidant, protect the integrity of biofilm, improve egg production rate, fertilization rate, hatchability rate; vitamins D3 promotes the absorption of calcium and phosphorus in the gastrointestinal tract and improves the immune function; when the poultry lacks vitamin K, it is easy to bleed and not easy to solidify. Therefore, based on the above factors, the present invention uses a particulate carrier to coat the vitamin A, D3, E, and K3 materials, and then prepares a comprehensive vitamin particle carrier-containing poultry beverage additive, which can prevent the problem of uneven intake of vitamins in poultry diets. .
本發明提供一種大豆卵磷脂包覆維生素之複方微脂粒添加物,主要包含以卵磷脂分別包覆維生素A、D3、E、K3之四種微脂粒。The invention provides a compound lipid particle supplement of soy lecithin coated vitamins, which mainly comprises four kinds of lipid particles coated with vitamin A, D3, E and K3 by lecithin.
維生素分為脂溶性維生素和水溶性維生素兩類,維生素A能幫助家禽視覺機能,繁殖機能,免疫機能;維生素E達到抗氧化,保護生物膜完整,提高產蛋率,受精率,孵化率;維生素D3則促進腸胃對鈣磷的吸收,提高免疫機能;家禽缺乏維生素K時,容易出血且不易凝固。因此本發明基於上列因素,利用卵磷脂包覆維生素A、D3、E及K3材料之後,製成一種綜合性含維生素微粒載體之家禽飲品添加物,將可預防家禽飲食維生素攝取不均勻的問題。Vitamins are divided into fat-soluble vitamins and water-soluble vitamins. Vitamin A can help poultry visual function, reproduction function, immune function; vitamin E can achieve antioxidant, protect the integrity of biofilm, improve egg production rate, fertilization rate, hatchability rate; vitamins D3 promotes the absorption of calcium and phosphorus in the gastrointestinal tract and improves the immune function; when the poultry lacks vitamin K, it is easy to bleed and not easy to solidify. Therefore, based on the above factors, the invention uses lecithin to coat the vitamin A, D3, E and K3 materials, and then prepares a comprehensive vitamin microparticle-containing poultry drink additive, which can prevent the problem of uneven intake of vitamins in poultry diets. .
微脂粒主要是卵磷脂中的磷脂質聚集而成的空心球,當磷脂質分散於水中時會自動形成双層膜結構體。實驗證明,微脂粒具有良好的生物相容性並對類骨質細胞有促進生長用(Huang, et al, 1997);微脂粒依粒徑大小及脂雙層數目分類,主要可分為單層小微脂粒(SUV's )、單層大微脂粒(LUV's )與多層微脂粒(MLV's )。Liposomes are mainly hollow spheres formed by the accumulation of phospholipids in lecithin. When phospholipids are dispersed in water, they will automatically form a double-layer membrane structure. Experiments have shown that liposomes have good biocompatibility and promote growth of osteoblast-like cells (Huang, et al, 1997); liposomes are classified according to particle size and number of lipid bilayers, and can be divided into single Layer of small liposomes (SUV's), single layer of large liposomes (LUV's) and multi-layered liposomes (MLV's).
參照圖1,圖1顯示本發明製備大豆卵磷脂包覆維生素之複方微脂粒添加物之方法流程圖。為了將本發明提供的大豆卵磷脂包覆維生素A、D3、E、K3之複方微脂粒添加物製成具有良好安定性與穩定性的產品,本發明在一較佳實施例中提供一種製備上述複方微脂粒添加物之方法,主要包括以下步驟:(a) 卵磷脂與乙醇配置成卵磷脂乙醇水溶液備用;首先將高純度(70%以上)卵磷脂與乙醇混合,配置成2%濃度的卵磷脂乙醇水溶液備用。(b) 維生素A、D3、E、K3依照其重量比分別與卵磷脂乙醇水溶液混合;將該維生素A、D3、E、K3依照其重量比,分別與該2%濃度的卵磷脂乙醇水溶液混合,形成不同濃度之維生素卵磷脂乙醇水溶液。(c) 不同濃度之維生素卵磷脂乙醇水溶液分別進行減壓濃縮形成薄膜;將不同濃度之該些維生素卵磷脂乙醇水溶液分別進行減壓濃縮形成薄膜。(d) 將薄膜加入純水或乙醇震盪至薄膜全數融入水中取得多層微脂粒溶液;將該些薄膜分別加入純水或乙醇,以震盪機震盪至薄膜全數掉落融入水中,取得多層微脂粒溶液。(e) 多層微脂粒溶液使用超音波震碎取得不同濃度的維生素微脂粒水溶液;將該些多層微脂粒溶液分別使用超音波細胞震碎機震盪後取得不同濃度的維生素A、D3、E、K3微脂粒水溶液。(f) 混合不同濃度的維生素微脂粒水溶液形成複方微脂粒添加物。混合該些不同濃度的維生素A、D3、E、K3微脂粒水溶液形成複方微脂粒添加物。Referring to FIG. 1, FIG. 1 shows a flow chart of the method for preparing a compound liposome particle supplement of soybean lecithin-coated vitamins of the present invention. In order to make the compound lipid particle supplement of vitamin A, D3, E, K3 provided by the soybean lecithin provided by the present invention into a product with good stability and stability, the present invention provides a preparation in a preferred embodiment The method of the compound lipid particle additive mentioned above mainly includes the following steps: (a) Lecithin and ethanol are configured as a lecithin ethanol aqueous solution for use; first, high-purity (more than 70%) lecithin and ethanol are mixed to a 2% concentration The ethanol solution of lecithin is ready for use. (b) Vitamins A, D3, E, and K3 are mixed with an aqueous solution of lecithin ethanol according to their weight ratio; the vitamins A, D3, E, and K3 are mixed with the aqueous solution of 2% concentration of lecithin ethanol according to their weight ratio, respectively , To form different concentrations of vitamin lecithin ethanol aqueous solution. (c) Different concentrations of vitamin lecithin ethanol aqueous solutions were concentrated under reduced pressure to form thin films; different concentrations of these vitamin lecithin ethanol aqueous solutions were concentrated under reduced pressure to form thin films. (d) Add the film to pure water or ethanol and shake until the film is fully incorporated into the water to obtain a multi-layered lipid solution; add these films to pure water or ethanol and shake with a oscillating machine until all the film falls into the water and obtain a multi-layered lipid Grain solution. (e) Ultrasonic shattering of the multi-layer liposome solution to obtain aqueous solutions of vitamin liposomes with different concentrations; these multi-layer liposome solutions were shaken with an ultrasonic cell shaker to obtain vitamin A, D3, E. K3 liposome aqueous solution. (f) Mix different concentrations of vitamin liposome aqueous solution to form a compound liposome additive. The vitamin A, D3, E, K3 liposome aqueous solutions of different concentrations are mixed to form a compound liposome additive.
以上步驟的內容分別詳細說明如下:The contents of the above steps are described in detail as follows:
步驟(a),卵磷脂與乙醇配置成卵磷脂乙醇水溶液備用,將卵磷脂2g加入99.5%乙醇定量至100mL,配置成2%卵磷脂乙醇水溶液備用。其中卵磷脂可直接使用高純度(70%以上)卵磷脂,但由於高純度(70%以上)卵磷脂價格高昂,亦可選擇於本步驟前自行以市售相較價格低廉的低純度(70%以下) 卵磷脂進行萃取製備,萃取製備之方法於後詳述。In step (a), lecithin and ethanol are configured as a lecithin ethanol aqueous solution for standby, and 2 g of lecithin is added to 99.5% ethanol for quantitative measurement to 100 mL, and configured as a 2% lecithin ethanol aqueous solution for standby. Among them, lecithin can directly use high-purity (more than 70%) lecithin, but due to the high price of high-purity (more than 70%) lecithin, you can also choose to use the commercially available low-purity low-purity (70 %) Lecithin is extracted and prepared. The method of extraction and preparation will be described in detail later.
步驟(b) 維生素A、D3、E、K3依照其重量比分別與卵磷脂乙醇水溶液混合;將該維生素A、D3、E、K3依照其重量比,分別與該2%濃度的卵磷脂乙醇水溶液混合,形成不同濃度之維生素卵磷脂乙醇水溶液。Step (b) Vitamins A, D3, E, and K3 are mixed with an aqueous solution of lecithin ethanol according to their weight ratio; the vitamins A, D3, E, and K3 are mixed with the aqueous solution of 2% concentration of lecithin ethanol according to their weight ratio, respectively Mix to form ethanol solution of vitamin lecithin with different concentrations.
其中,維生素A卵磷脂乙醇水溶液係以上述2%卵磷脂乙醇水溶液100mL與0.01%~0.1%維生素A一起倒入茄型瓶,該維生素A可以先與乙醇混合製備成0.01%~0.1%維生素A乙醇溶液100mL,再與2%卵磷脂乙醇水溶液100mL共同倒入茄型瓶。Among them, the vitamin A lecithin ethanol aqueous solution is 100ml of the above 2% lecithin ethanol aqueous solution and 0.01%~0.1% vitamin A is poured into the eggplant type bottle, the vitamin A can be mixed with ethanol to prepare 0.01%~0.1% vitamin A 100mL of ethanol solution, then pour into eggplant type bottle together with 100mL of 2% lecithin ethanol aqueous solution.
其中,維生素D3卵磷脂乙醇水溶液係以上述2%卵磷脂乙醇水溶液100mL與0.2%~0.5%維生素D3一起倒入茄型瓶,該維生素D3可以先與乙醇混合製備成0.2%~0.5%維生素D3乙醇溶液100mL,再與2%卵磷脂乙醇水溶液100mL共同倒入茄型瓶。Among them, the vitamin D3 lecithin ethanol aqueous solution is poured into the eggplant-shaped bottle with the above 2% lecithin ethanol aqueous solution 100mL and 0.2%~0.5% vitamin D3. The vitamin D3 can be mixed with ethanol to prepare 0.2%~0.5% vitamin D3 100mL of ethanol solution, then pour into eggplant type bottle together with 100mL of 2% lecithin ethanol aqueous solution.
其中,維生素E卵磷脂乙醇水溶液係以上述2%卵磷脂乙醇水溶液100mL與0.2%~0.4%維生素E一起倒入茄型瓶,該維生素E可以先與乙醇混合製備成0.2%~0.4%維生素E乙醇溶液100mL,再與2%卵磷脂乙醇水溶液100mL共同倒入茄型瓶。Among them, the vitamin E lecithin ethanol aqueous solution is 100ml of the above 2% lecithin ethanol aqueous solution and 0.2%~0.4% vitamin E is poured into the eggplant type bottle, the vitamin E can be mixed with ethanol to prepare 0.2%~0.4% vitamin E 100mL of ethanol solution, then pour into eggplant type bottle together with 100mL of 2% lecithin ethanol aqueous solution.
步驟(c) 不同濃度之維生素卵磷脂乙醇水溶液分別進行減壓濃縮形成薄膜;將不同濃度之該些維生素卵磷脂乙醇水溶液分別以減壓濃縮機轉速110rpm、水浴鍋溫度37±1℃條件進行減壓濃縮約10~15分鐘去除有機溶劑,形成薄膜後取下。Step (c) Different concentrations of vitamin lecithin ethanol aqueous solution are concentrated under reduced pressure to form a thin film; the different concentrations of these vitamin lecithin ethanol aqueous solutions are reduced at a reduced pressure concentrator speed of 110 rpm and a water bath temperature of 37±1° C. Press to concentrate for about 10~15 minutes to remove the organic solvent, remove it after forming a film.
步驟(d) 將薄膜加入純水或乙醇震盪至薄膜全數融入水中取得多層微脂粒溶液;將該些薄膜分別加入純水或乙醇,以震盪機震盪至薄膜全數掉落融入水中,取得多層微脂粒溶液(MLVs)。Step (d) Add the film to pure water or ethanol and shake until the film is fully incorporated into the water to obtain a multi-layer lipid solution; add these films to pure water or ethanol respectively and shake with a oscillating machine until all the film falls into the water and obtain a multi-layer micro-lipid Lipid solutions (MLVs).
其中,維生素A之薄膜係倒入200mL純水,使用試管震盪機震盪至薄膜全數掉落融入水中。Among them, the film of vitamin A was poured into 200mL of pure water, and shaken with a test tube shaker until all the film fell into the water.
其中,維生素D3之薄膜係倒入200mL純水,使用試管震盪機震盪至薄膜全數掉落融入水中。Among them, the film of vitamin D3 was poured into 200mL of pure water, and shaken with a test tube shaker until all the film fell into the water.
其中,維生素K3之薄膜係倒入200mL純水,使用試管震盪機震盪至薄膜全數掉落融入水中。Among them, the film of vitamin K3 was poured into 200mL of pure water, and shaken with a test tube shaker until all the film fell into the water.
其中,由於維生素E不溶於水,維生素E之薄膜係倒入200mL 25%乙醇水,使用試管震盪機震盪至薄膜全數掉落融入水中。Among them, because vitamin E is insoluble in water, the film of vitamin E is poured into 200 mL of 25% ethanol water, and shaken with a test tube shaker until all the film falls into the water.
步驟(e) 多層微脂粒溶液使用超音波震碎取得不同濃度的維生素微脂粒水溶液;將該些多層微脂粒溶液分別使用超音波細胞震碎機震盪後取得不同濃度的維生素A、D3、E、K3微脂粒水溶液。先以水浴超音波洗淨器以700w條件震盪20至40分鐘,讓維生素微脂粒水更加均勻,再以探針式超音波細胞粉碎機以35w條件震盪30分鐘(每10分鐘將外鍋水進行換水,避免震盪溫度提升),最後可以取得具有單層維脂粒(SUV)的不同濃度維生素微脂粒水溶液。Step (e) Ultrasonic shredding of the multi-layered liposome solution to obtain aqueous solutions of vitamin liposomes with different concentrations; after shaking these multi-layered liposome solutions with an ultrasonic cell shaker, respectively, to obtain vitamins A and D3 with different concentrations , E, K3 liposome aqueous solution. First, shake with a water bath ultrasonic cleaner at 700w for 20 to 40 minutes to make the vitamin liposome water more uniform, and then use a probe-type ultrasonic cell crusher to shake at 35w for 30 minutes (every 10 minutes, the outer pot of water Perform water exchange to avoid the increase of shock temperature), and finally obtain an aqueous solution of vitamin lipid particles with different concentrations of single-layer vitamin fat particles (SUV).
其中,最後取得的維生素A微脂粒水溶液較佳為濃度0.5%維生素A微脂粒水溶液。Among them, the finally obtained aqueous solution of vitamin A liposomes is preferably an aqueous solution of 0.5% vitamin A liposomes.
其中,最後取得的維生素D3微脂粒水溶液較佳為濃度0.25%維生素D3微脂粒水溶液。Among them, the finally obtained aqueous solution of vitamin D3 liposomes is preferably an aqueous solution of 0.25% vitamin D3 liposomes.
其中,最後取得的維生素E微脂粒水溶液較佳為濃度0.2%維生素E微脂粒水溶液。Among them, the finally obtained aqueous solution of vitamin E liposomes is preferably a 0.2% aqueous solution of vitamin E liposomes.
其中,最後取得的維生素K3微脂粒水溶液較佳為濃度1%維生素K3微脂粒水溶液。Among them, the finally obtained aqueous solution of vitamin K3 liposomes is preferably an aqueous solution of vitamin K3 liposomes with a concentration of 1%.
步驟(f) 混合不同濃度的維生素微脂粒水溶液形成複方微脂粒添加物。混合該些不同濃度的維生素A、D3、E、K3微脂粒水溶液形成複方微脂粒添加物。Step (f) Mix aqueous solutions of vitamin liposomes with different concentrations to form a compound liposome supplement. The vitamin A, D3, E, K3 liposome aqueous solutions of different concentrations are mixed to form a compound liposome additive.
本發明為了使卵磷脂包覆維生素A、D3、E及K3等材料之後能具有良好的安定性,進行以下試驗。前述製備方法的步驟(b) 中,維生素A、D3、E、K3分別與卵磷脂乙醇水溶液混合的重量比係依照下列試驗所得到的結果。In the present invention, in order to make lecithin coat vitamin A, D3, E, K3 and other materials with good stability, the following tests were conducted. In step (b) of the foregoing preparation method, the weight ratio of vitamins A, D3, E, and K3 mixed with the aqueous lecithin ethanol solution is based on the results obtained by the following tests.
進行試驗時首先取高純度(純度70%以上)之卵磷脂2g加入99.5%乙醇定量至100mL,配置成2%卵磷脂乙醇水溶液備用,並備置不同濃度維生素乙醇溶液進行備置依其分組,組成不同比例維生素微脂粒配方,其維生素A、D3 、E配方比例如表1、2、3所示,而維生素K3 則使用純水進行配置,其配方比例如表4所示。When conducting the experiment, first take 2g of high-purity (purity above 70%) lecithin and add 99.5% ethanol to 100mL, configure it as a 2% lecithin ethanol aqueous solution for standby, and prepare different concentrations of vitamin ethanol solution for preparation according to its grouping, the composition is different Proportioned vitamin liposome formula, its vitamin A, D 3 and E formula ratios are shown in Tables 1, 2, and 3, while vitamin K 3 is configured using pure water, and its formula ratio is shown in Table 4.
表1微生素A微脂粒配方比例表
表2微生素D3 微脂粒配方比例表Table 2 Probiotics D 3 liposome formula ratio table
表4微生素K3微脂粒配方比例表
維生素微脂粒之安定性試驗:Stability test of vitamin liposomes:
依表1、2、3、4配置不同配方比例之微脂粒維生素,觀察30天內有無浮油、有無分層或有無沈澱現象,結果顯示維生素A、D3、E、K3微脂粒各自的穩定比例不同。According to Tables 1, 2, 3, and 4, configure liposome vitamins with different formulation ratios, observe whether there is oil slick, layering or precipitation in 30 days, the results show that vitamin A, D3, E, K3 liposomes Stability ratio is different.
參照下表,表5為維生素A不同濃度之安定性評估表,考量2%卵磷脂乙醇水溶液與0.2%維生素A乙醇水溶液配置之比例在第20天時候已產生分層現象,經過30天安定性評估證明0.1%以下維生素A微脂粒無分層現象,因此以0.01%~0.1%維生素A乙醇水溶液濃度進行維生素A微脂粒製備,確定是可以製成安定性高的大豆卵磷脂包覆維生素之複方微脂粒添加物。Referring to the following table, Table 5 is the stability assessment table for different concentrations of vitamin A. Considering the ratio of the configuration of 2% lecithin ethanol solution to 0.2% vitamin A ethanol solution, stratification has occurred on the 20th day, after 30 days of stability The evaluation proves that there is no stratification of vitamin A liposomes below 0.1%, so the preparation of vitamin A liposomes at a concentration of 0.01% to 0.1% vitamin A in ethanol is determined to be a highly stable soybean lecithin-coated vitamin The compound liposome additive.
表5 維生素A不同濃度之安定性評估表
參照下表,表6為維生素D3不同濃度之安定性評估表,考量2%卵磷脂乙醇水溶液與0.6%維生素D3乙醇水溶液配置之比例在第30天時候已產生分層現象,因此以0.2%~0.5%維生素D3乙醇水溶液濃度進行維生素D3微脂粒製備,確定是可以製成安定性高的大豆卵磷脂包覆維生素之複方微脂粒添加物。Referring to the following table, Table 6 is the stability assessment table for different concentrations of vitamin D3. Considering the ratio of the configuration of 2% lecithin ethanol solution to 0.6% vitamin D3 ethanol solution, stratification has occurred on the 30th day, so 0.2%~ The preparation of vitamin D3 liposomes with a concentration of 0.5% vitamin D3 in ethanol was determined to be a compound liposome additive with high stability of soybean lecithin-coated vitamins.
表6維生素D3不同濃度之安定性評估表
參照下表,表7為維生素E不同濃度之安定性評估表,維生素E配置過程中,僅使用純水作為震盪溶劑時,發現無法將卵磷脂維生素E乙醇水溶液薄膜震盪融入,因此分別調製5%、10%、15%、20%、25%不同濃度乙醇水進行製作,結果顯示以25%乙醇水震盪融入效果最佳,並為使均勻以超音波洗淨器震盪二次總共40分鐘。其中濃度0.6%維生素E乙醇水溶液配置之比例在第20天時候已產生分層現象,因此降低維生素E乙醇水溶液濃度至0.4%進行製作,卵磷脂乙醇水溶液與維生素E乙醇水溶液比例為2:0.4為穩定配方比例,實驗經過30天安定性評估證明,0.4%維生素E微脂粒無分層現象,因此以0.2%~0.4%維生素E乙醇水溶液濃度進行維生素E微脂粒製備,確定是可以製成安定性高的大豆卵磷脂包覆維生素之複方微脂粒添加物。
表7維生素E不同濃度之安定性評估表Table 7 Stability assessment table for different concentrations of vitamin E
參照下表,表8為維生素K3不同濃度之安定性評估表,維生素K3為人工合成維生素,不溶解於乙醇,因此在備置時先以純水溶解,於震盪卵磷脂乙醇水溶液薄膜時加入,卵磷脂乙醇水溶液與維生K3水穩定比例為2:1。2%卵磷脂乙醇水溶液與1%維生素K3水溶液配置之比例在第30天時候已產生分層現象,因此以0.4%~1%維生素K3乙醇水溶液濃度進行維生素K3 微脂粒製備,確定是可以製成安定性高的大豆卵磷脂包覆維生素之複方微脂粒添加物。Refer to the following table. Table 8 is the stability assessment table for different concentrations of vitamin K3. Vitamin K3 is a synthetic vitamin and is not soluble in ethanol. Therefore, when prepared, it is dissolved in pure water first and added when shaking the membrane of aqueous lecithin ethanol solution. The stable ratio of phospholipid ethanol aqueous solution and vitamin K3 water is 2: 1. The ratio of the configuration of 2% lecithin ethanol aqueous solution and 1% vitamin K3 aqueous solution has stratified phenomenon on the 30th day, so 0.4%~1% vitamin K3 The preparation of vitamin K 3 liposomes with the concentration of ethanol aqueous solution was determined to be a compound liposome additive with high stability of soybean lecithin-coated vitamins.
表8維生素K3不同濃度之安定性評估表
通過以上試驗數據可以得知,本發明之大豆卵磷脂包覆維生素之複方微脂粒添加物,包含以卵磷脂分別包覆維生素A、D3、E、K3之四種微脂粒,其卵磷脂與該維生素A之重量比較佳為2:0.01至2:0.1,該卵磷脂與該維生素D3之重量比較佳為2:0.2至2:0.5,該卵磷脂與該維生素E之重量比較佳為2:0.2至2:0.4,該卵磷脂與該維生素K3之重量比較佳為2:0.4至2:1。其中,上述比例於該卵磷脂與該維生素A之重量比為2:0.1,該卵磷脂與該維生素D3之重量比為2:0.5,該卵磷脂與該維生素E之重量比為2:0.4,該卵磷脂與該維生素K3之重量比為2:1時,可以得到安定性良好且維生素含量較高的配比。It can be known from the above test data that the soy lecithin-coated vitamin compound liposome supplement of the present invention includes four liposomes coated with vitamin A, D3, E, and K3 with lecithin, and their lecithin The weight comparison with the vitamin A is preferably 2:0.01 to 2:0.1, the weight comparison between the lecithin and the vitamin D3 is preferably 2:0.2 to 2:0.5, and the weight comparison between the lecithin and the vitamin E is preferably 2 :0.2 to 2:0.4, the weight of the lecithin and the vitamin K3 is preferably 2:0.4 to 2:1. The weight ratio of the lecithin to the vitamin A is 2:0.1, the weight ratio of the lecithin to the vitamin D3 is 2:0.5, and the weight ratio of the lecithin to the vitamin E is 2:0.4. When the weight ratio of the lecithin to the vitamin K3 is 2:1, the compounding ratio with good stability and high vitamin content can be obtained.
參照圖3至圖6,圖3顯示本發明複方微脂粒添加物中卵磷脂成功包覆維生素A之穿透式顯微鏡觀察檢測圖,圖4顯示本發明複方微脂粒添加物中卵磷脂成功包覆維生素D3之穿透式顯微鏡觀察檢測圖,圖5顯示本發明複方微脂粒添加物中卵磷脂成功包覆維生素E之穿透式顯微鏡觀察檢測圖。圖6顯示本發明複方微脂粒添加物中卵磷脂成功包覆維生素K3之穿透式顯微鏡觀察檢測圖。微脂粒因備置成分濃度及方式不同,產生影響脂質變化,本發明進行實驗配置不同維生素濃度與2%卵磷脂乙醇水溶液進行配置,觀察其微脂粒粒型,使用微量吸管取備置的微脂粒維生素溶液樣品200ul定量加入10mL純水進行稀釋,滴入稀釋液至銅網上,進行冷凍乾燥後取出進行穿透式顯微鏡觀察檢測,實驗證明本發明之製備複方微脂粒添加物之方法,皆能成功包覆維生素A、D3、E及K3。Referring to FIGS. 3 to 6, FIG. 3 shows the penetration microscopy observation test chart of the successful application of lecithin in the compound liposome particle supplement of the present invention, and FIG. 4 shows the successful lecithin in the compound liposome particle supplement of the present invention The penetrating microscope observation and detection diagram of coated vitamin D3. FIG. 5 shows the penetrating microscope observation and detection diagram of successfully coating vitamin E with lecithin in the compound liposome supplement of the present invention. Fig. 6 shows the penetration microscopy observation detection diagram of the vitamin K3 successfully coated with lecithin in the compound lipid particle supplement of the present invention. The lipid particles have different effects on lipid changes due to the different concentration and method of the prepared components. The present invention conducts experiments to configure different vitamin concentrations and 2% lecithin ethanol aqueous solution to observe the lipid particle size, and uses a micro pipette to obtain the prepared lipid 200ul of the vitamin solution sample was quantitatively added with 10mL of pure water for dilution, dripped into the dilution solution on the copper mesh, lyophilized and taken out for observation through a transmission microscope, and the experiment proved that the method for preparing compound liposome additives of the present invention, All can successfully coat vitamin A, D3, E and K3.
參照圖2,顯示本發明製備複方微脂粒添加物中的卵磷脂之萃取方法流程圖。本發明使用之卵磷脂可以利用純度較低價格也較低的低純度食品卵磷脂以丙酮及乙醇進行萃取取得純度70%以上之該卵磷脂。本發明所使用之低純度食品卵磷脂,於本實施例較佳但不限為價格較低的純度30%左右之食品卵磷脂,本發明所指之低純度食品卵磷脂應包含純度70%以下之食品卵磷脂。Referring to FIG. 2, it shows a flow chart of the method for extracting lecithin in the compound lipid particle supplement of the present invention. The lecithin used in the present invention can be extracted with acetone and ethanol using low-purity food lecithin with lower purity and lower price to obtain the lecithin with a purity of more than 70%. The low-purity food lecithin used in the present invention is preferred in this embodiment, but not limited to food lecithin with a purity of about 30%, which is relatively inexpensive, and the low-purity food lecithin referred to in the present invention should contain a purity of less than 70% The food lecithin.
其中,該卵磷脂之萃取方法較佳係以如下步驟進行:(g) 將低純度大豆卵磷脂與丙酮依1:2重量比例混合攪拌;將純度30%左右之低純度食品卵磷脂與丙酮依1:2重量比例混合,使用電磁加熱攪拌器攪拌後靜置取去上層清液。(h) 重複步驟(g)二次。(i)最後一次攪拌完畢後進行抽氣過濾取其沉澱物。(j) 沉澱物與乙醇以1:2重量比例混合,使用攪拌器攪拌,攪拌後進行抽氣過濾取得溶液;將該沉澱物與純度95%乙醇1:2重量比例混合,使用電磁加熱攪拌器攪拌,每次攪拌後立即進行抽氣過濾。(k) 重複步驟(j)二次,以減壓濃縮法去除溶劑取得純度70%以上之卵磷脂;再重複乙醇萃取的步驟(j)二次,最後一次過濾後取得溶液,然後進行減壓濃縮將溶劑完全去除取得純度70%以上之該卵磷脂。Among them, the method for extracting lecithin is preferably carried out in the following steps: (g) Mix and stir low-purity soybean lecithin and acetone in a weight ratio of 1:2; mix low-purity food lecithin and acetone according to a purity of about 30% 1:2 weight ratio mixing, use an electromagnetic heating stirrer to stir and then stand to remove the supernatant. (h) Repeat step (g) twice. (i) After the last stirring, perform suction filtration to take the precipitate. (j) The precipitate is mixed with ethanol at a weight ratio of 1:2 and stirred using a stirrer. After stirring, the solution is suctioned and filtered to obtain a solution; the precipitate is mixed with a purity of 95% ethanol at a weight ratio of 1:2 and an electromagnetic heating stirrer is used Stir, perform suction filtration immediately after each stirring. (k) Repeat step (j) twice, and remove the solvent by vacuum concentration to obtain lecithin with a purity of more than 70%; repeat the ethanol extraction step (j) twice, and obtain the solution after the last filtration, and then decompress Concentration removes the solvent completely to obtain the lecithin with a purity of more than 70%.
萃取方法參考溶劑萃取法,先將市售的低純度食品卵磷脂與丙酮依1:2比例使用電磁加熱攪拌器以磁石攪拌30分鐘,靜置30分鐘後後取去上層清液,此步驟再重複二次,最後一次攪拌完畢後進行抽氣過濾,取其沉澱物放至燒杯中,再依照食品卵磷脂:95 %乙醇=1:2的比例同樣使用電磁加熱攪拌器以磁石攪拌30分鐘,進行一至四次相同步驟,每次攪拌後立即進行抽氣過濾,過濾後取得溶液進行減壓濃縮(110rpm,37±1℃,時間約2小時),將溶劑完全去除即可取得精煉後卵磷脂,隨即秤重計算其萃取率。For the extraction method, refer to the solvent extraction method. First, the commercially available low-purity food lecithin and acetone are stirred with a magnet using an electromagnetic heating stirrer at a ratio of 1:2 for 30 minutes. After standing for 30 minutes, the supernatant is removed, and then this step is used. Repeat twice. After the last stirring, perform suction filtration, take the precipitate into the beaker, and then use the electromagnetic heating stirrer to stir the magnet for 30 minutes according to the ratio of food lecithin: 95% ethanol = 1:2. Perform the same steps one to four times, and perform suction filtration immediately after each stirring. After filtration, the solution is concentrated under reduced pressure (110rpm, 37±1℃, time about 2 hours), and the solvent can be completely removed to obtain refined lecithin. , Then weighed to calculate the extraction rate.
本發明於實驗中將市售的低純度食品卵磷脂以丙酮三次、95%乙醇三次進行萃取,其卵磷脂純度能提升到73.7 ± 2.2%,回收率為84.8 ± 4.6%。In the present invention, the commercially available low-purity food lecithin is extracted three times with acetone and 95% ethanol three times. The purity of the lecithin can be increased to 73.7 ± 2.2%, and the recovery rate is 84.8 ± 4.6%.
另外,對本發明方法製成之大豆卵磷脂包覆維生素之複方微脂粒添加物進行微脂粒之粒徑分析,分析方式係以粒徑分析儀(Malvern Zetasizer Nano ZS)分析奈米結構脂質載體粒徑和多分散係數(Polydispersity index,PDI)分佈值。粒徑量測時先將樣品槽放入儀器內反覆測量三次,最後就重複實驗之測量結果求其平均值及標準差。In addition, the particle size analysis of the liposomes was performed on the compound lipid particle supplement of soy lecithin-coated vitamins prepared by the method of the present invention. The analysis method was to analyze the nanostructured lipid carrier with a particle size analyzer (Malvern Zetasizer Nano ZS). Particle size and polydispersity index (Polydispersity index, PDI) distribution value. When measuring the particle size, first put the sample tank into the instrument and measure it repeatedly three times. Finally, repeat the measurement results of the experiment to find the average and standard deviation.
微脂粒因備置成分濃度及方式不同,產生影響脂質變化,本發明於分析時配置不同維生素濃度與2%磷脂質乙醇溶液進行配置,觀察其微脂粒粒徑。參照以下表9至表12,微脂粒維生素A、D3、E、K3各配方比例2:0.1、2:0.5、2:0.4、2:1製成維生素微脂粒,將四組樣品進行重覆在23±2℃、4℃、45℃、4℃/45℃四種不同條件下,觀察微脂粒經過30天之安定性發現,維生素A微脂粒於23±2℃及4 ℃變化下其粒徑安定性不會有明顯之變化趨勢,而維生素D3、E、K3微脂粒於4 ℃下其安定性不會有明顯之變化,以上微脂粒粒徑約在123.3±0.5 nm至319.98±44.8 nm之間。通過以上觀察結果證實,本發明製成之包覆維生素的微脂粒安定性不會有明顯之變化。The lipid particles have different concentrations and methods of the prepared components, which affect the lipid changes. In the present invention, different vitamin concentrations and a 2% phospholipid ethanol solution are arranged during the analysis, and the particle size of the lipid particles is observed. Referring to the following Table 9 to Table 12, the liposome vitamin A, D3, E, K3 formula ratio of 2:0.1, 2:0.5, 2:0.4, 2:1 to prepare vitamin liposome, the four groups of samples were weighed Covered under four different conditions of 23±2℃, 4℃, 45℃, 4℃/45℃, after observing the stability of liposomes for 30 days, it was found that vitamin A liposomes changed at 23±2℃ and 4 ℃ The stability of the particle size will not change significantly, but the stability of vitamin D3, E, K3 liposomes at 4 ℃ will not change significantly. The particle size of the above liposomes is about 123.3±0.5 nm To 319.98±44.8 nm. From the above observation results, it is confirmed that the stability of the vitamin-coated liposomes made by the present invention will not change significantly.
表9維生素A不同溫度之微脂粒性質比較表
表10維生素D3
不同溫度之微脂粒性質比較表
表11維生素E不同溫度之微脂粒性質比較表
表12維生素K3
不同溫度之微脂粒性質比較表
本發明參考一般肉雞飼養方式利用傳統圈養方式進行飼養以進行有效性評估分析,有效性評估分析,每8天進行一次秤重,每組同步飼養35天。A組為本發明大豆卵磷脂包覆維生素之複方微脂粒添加物製成之維生素水溶液,B組維生素水的製作係以A組維生素水溶液的濃度加入10g食品級乳化劑調配製成,並將A組與B組同比例稀釋1000倍至市售配方濃度,在雛雞階段(1~10天)每日添加500mL至飲用水一天一次,脫毛階段的中齡雞(11~25天)每日添加1000mL至飲用水一天一次,成雞(26~35天)飲水量較高美日添加1000mL至飲用水一天兩次,皆於每日6:30供飲用水,前一天晚上22:30停水,以確保雞隻確實飲用水。The invention refers to the general broiler feeding method and uses the traditional captive feeding method to perform the effectiveness evaluation and analysis. The effectiveness evaluation and analysis are weighed once every 8 days, and each group is synchronously fed for 35 days. Group A is a vitamin aqueous solution made of the compound lipid particle additive of soybean lecithin-coated vitamins of the present invention. Group B vitamin water is prepared by adding 10g of food-grade emulsifier at the concentration of group A vitamin aqueous solution, and Group A and Group B are diluted 1000 times in the same proportion to the concentration of commercially available formula. 500mL is added to drinking water once a day in the chick stage (1-10 days), and medium-age chickens in the hair removal stage (11-25 days) are added daily 1000mL to drinking water once a day, adult chickens (26~35 days) drink a higher amount of water. US and Japan add 1000mL to drinking water twice a day, both provide drinking water at 6:30 every day, and stop water at 22:30 the night before, To ensure that the chickens are drinking water.
參照表13,結果發現,本發明複方維生素微脂粒之組別雞隻均重為2264.1±609.5 g,飼料轉換率為4.9%,而維生素水溶液之組別雞隻均重為2093.5±380.3 g,飼料轉換率為5.2%,實驗結果證明微脂粒包覆維生素A、D3 、E、K3 之複方,能有效的幫助雞隻成長。Referring to Table 13, it was found that the average weight of chickens in the compound vitamin lipid particles of the present invention was 2264.1±609.5 g, and the feed conversion rate was 4.9%, while the average weight of chickens in the vitamin aqueous solution group was 2093.5±380.3 g. The feed conversion rate is 5.2%. The experimental results show that the combination of vitamin A, D 3 , E, and K 3 with liposomes can effectively help chickens grow.
表13家禽平均體重 n=16,Mean±S.D.
本發明已利用上述較佳實施例揭示,惟其並非用以限定本發明。 本發明所屬技術領域中具有通常知識者,應清楚了解本發明並不受限於上述說明性實施方式的細節,本發明得以其他特定形式實施而不脫離本發明之基本精神,實施方式僅為說明本發明,而非限制本發明,本發明以申請專利範圍為依據,而非以上述說明為依據,申請專利範圍之意義及均等範圍中所有變型均屬本發明之範圍。The present invention has been disclosed using the above preferred embodiments, but it is not intended to limit the present invention. Those with ordinary knowledge in the technical field to which the present invention pertains should clearly understand that the present invention is not limited to the details of the above illustrative embodiments. The present invention can be implemented in other specific forms without departing from the basic spirit of the present invention. The embodiments are merely illustrative The present invention does not limit the present invention. The present invention is based on the scope of patent application, rather than the above description. All the modifications and meanings in the scope of patent application are within the scope of the present invention.
a~f‧‧‧步驟g~k‧‧‧步驟a~f‧‧‧step g~k‧‧‧step
圖1顯示本發明製備大豆卵磷脂包覆維生素之複方微脂粒添加物之方法流程圖。 圖2顯示本發明製備複方微脂粒添加物中的卵磷脂之萃取方法流程圖。 圖3顯示本發明複方微脂粒添加物中卵磷脂成功包覆維生素A之穿透式顯微鏡觀察檢測圖。 圖4顯示本發明複方微脂粒添加物中卵磷脂成功包覆維生素D3之穿透式顯微鏡觀察檢測圖。 圖5顯示本發明複方微脂粒添加物中卵磷脂成功包覆維生素E之穿透式顯微鏡觀察檢測圖。 圖6顯示本發明複方微脂粒添加物中卵磷脂成功包覆維生素K3之穿透式顯微鏡觀察檢測圖。FIG. 1 shows a flow chart of the method for preparing a compound liposome particle supplement of soybean lecithin-coated vitamins of the present invention. FIG. 2 shows a flow chart of the method for extracting lecithin from the compound liposome particle supplement of the present invention. FIG. 3 shows a transmission microscope observation and detection diagram of the lecithin in the compound liposome supplement of the present invention successfully coated with vitamin A. FIG. Fig. 4 shows the penetration microscopy observation and detection diagram of the lecithin in the compound liposome supplement of the present invention successfully coated with vitamin D3. FIG. 5 shows the penetration microscopy observation and detection diagram of the lecithin in the compound liposome supplement of the present invention successfully coated with vitamin E. FIG. Fig. 6 shows the penetration microscopy observation detection diagram of the vitamin K3 successfully coated with lecithin in the compound lipid particle supplement of the present invention.
a~f‧‧‧步驟 a~f‧‧‧step
Claims (8)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW107120545A TW202000037A (en) | 2018-06-14 | 2018-06-14 | Compound liposome additive of soy lecithin-coated vitamin and preparing method thereof capable of effectively enhancing growth of chicken |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW107120545A TW202000037A (en) | 2018-06-14 | 2018-06-14 | Compound liposome additive of soy lecithin-coated vitamin and preparing method thereof capable of effectively enhancing growth of chicken |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW202000037A true TW202000037A (en) | 2020-01-01 |
Family
ID=69941840
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW107120545A TW202000037A (en) | 2018-06-14 | 2018-06-14 | Compound liposome additive of soy lecithin-coated vitamin and preparing method thereof capable of effectively enhancing growth of chicken |
Country Status (1)
| Country | Link |
|---|---|
| TW (1) | TW202000037A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114468307A (en) * | 2020-10-23 | 2022-05-13 | 大江生医股份有限公司 | Preparation method of liposome with capability of stably coating effective components |
-
2018
- 2018-06-14 TW TW107120545A patent/TW202000037A/en unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114468307A (en) * | 2020-10-23 | 2022-05-13 | 大江生医股份有限公司 | Preparation method of liposome with capability of stably coating effective components |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2296494B2 (en) | Infant milk formula with fat gradient | |
| CN106174598B (en) | An immune-boosting protein powder | |
| Geremew et al. | Proximate composition of commercially important fish species in southern Gulf of Lake Tana, Ethiopia | |
| CN101953429B (en) | Marine fish fortification microcapsule aqueous solution agent and preparation method thereof | |
| TW202000037A (en) | Compound liposome additive of soy lecithin-coated vitamin and preparing method thereof capable of effectively enhancing growth of chicken | |
| CN110559352B (en) | A kind of hawthorn flavonoid microcapsule and its preparation method and application | |
| CN113508888B (en) | Instant DHA yolk powder and preparation method thereof | |
| IL146069A (en) | Complete feed for fish larvae and method for preparing same | |
| WO2005096835A1 (en) | Dispersible protein composition | |
| CN109805351A (en) | A kind of preparation method of the enriched nutrient salt containing type vitamin A microcapsules | |
| CN106798335A (en) | The application of medium chain triglyceride | |
| JP5870321B1 (en) | Nutrients with high content of fine particle emulsified oil | |
| CN107467672B (en) | Preparation method of ferrous composite gel microspheres | |
| RU2317714C2 (en) | Biologically active additive based on cyst, or nauplii, or adult persons of naxillopod artemia salina for topic or oral administering | |
| CN118765984A (en) | A kind of oil gel and its preparation method and application | |
| JPH06237706A (en) | Method for growing juvenile bivalve using fine particle of artificial feed | |
| CN107041482A (en) | Special nano combined nutrition liquid formulation of a kind of Broiler chicks and preparation method thereof | |
| AU2018102207A4 (en) | Application of schizochytrium limacinum and preparation thereof in improvement of quality and yield of animal product | |
| CN115644314A (en) | Emulsified compound premix feed for livestock and preparation method thereof | |
| CN115152906A (en) | Shrimp milk powder formula and preparation method thereof | |
| CN113575942A (en) | Ginseng and pilose antler fruit nutrient lipid particle and preparation method thereof | |
| WO2018056898A1 (en) | Aquaculture feed and method of producing same | |
| CN110801043A (en) | Microcapsule for improving immunity of chronic disease patient and preparation method thereof | |
| CN118697009B (en) | Nano-microcapsules containing docosahexaenoic acid, preparation method and application thereof, and animal feed or food | |
| KR20110139879A (en) | Spirulina-edible oil complex and preparation method thereof |